clinical research prime

Senior Stomach Bug 60+

• A Phase 3, randomized, placebo-controlled study to evaluate the safety and efficacy of, a multivalent candidate vaccine to prevent Norovirus Acute Gastroenteritis in adults ≥60 Years of Age.
• Participants will receive study related prevention at no cost and will be compensated for time and travel.